← Back to Patent Explorer
US3989694A Expired / Lapsed US ⏱️ 0.0 years remaining

7-Acyl-3-(substituted triazolyl thiomethyl)cephalosporins

Assignee: GlaxoSmithKline LLC
•
Filing: 1974-12-27
•
Granted: 1976-11-02
•
Expires: 1994-12-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The compounds of this invention are cephalosporins having various acyl substituents at the 7-position and a substituted triazolyl thiomethyl group at the 3-position of the cephem nucleus and intermediates for the preparation thereof. The 7-acylated compounds have antibacterial activity.

Inventors

  • 👤 David A. Berges

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 04:51
CPC Classifications
C; C07; C07D; C07D501/00; C07D501/14; C07D501/16; C07D501/20; C07D501/24; C07D501/36; A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/54; A61K31/542; A61K31/545; C07D249/00; C07D249/02; C07D249/04; C07D249/08; C07D249/10; C07D249/12

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 121 words
A compound of the formula: ##SPC3## in which: R 1 is thienyl, phenyl or phenyl substituted with one or two groups selected from hydroxy, halo, nitro, hydroxymethyl, amino, lower alkylamino, di(lower)alkylamino, or carboxymethylamino, each alkyl having from one to four carbon atoms; X is amino or hydroxy; and Het is 1,2,4-triazolyl or 1,2,3-triazolyl each of which is substituted with --(CHR 2 ) n COR 3 , where R 2 is hydrogen or lower alkyl of from one to four carbon atoms, n is zero to six and R 3 is hydroxy, lower alkoxy of from one to four carbon atoms, amino, lower alkylamino or di(lower)alkylamino, each alkyl having from one to four carbon atoms, or a non-toxic pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 121 words
A compound of the formula: ##SPC3## in which: R 1 is thienyl, phenyl or phenyl substituted with one or two groups selected from hydroxy, halo, nitro, hydroxymethyl, amino, lower alkylamino, di(lower)alkylamino, or carboxymethylamino, each alkyl having from one to four carbon atoms; X is amino or hydroxy; and Het is 1,2,4-triazolyl or 1,2,3-triazolyl each of which is substituted with --(CHR 2 ) n COR 3 , where R 2 is hydrogen or lower alkyl of from one to four carbon atoms, n is zero to six and R 3 is hydroxy, lower alkoxy of from one to four carbon atoms, amino, lower alkylamino or di(lower)alkylamino, each alkyl having from one to four carbon atoms, or a non-toxic pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 23 words
A compound according to claim 1 in which Het is 1,2,3-triazol-5-yl or 1,2,4-triazol-3-yl, R 2 is hydrogen and n is zero to four.
Claim 4
Dependent Claim 14 words
A compound according to claim 2 in which R 1 is phenyl or hydroxyphenyl.
Claim 5
Dependent Claim 23 words
A compound according to claim 3 in which R 1 is phenyl or 4-hydroxyphenyl and R 3 is hydroxy, lower alkoxy or amino.
Claim 6
Dependent Claim 11 words
A compound according to claim 1 in which X is hydroxy.
Claim 7
Dependent Claim 11 words
A compound according to claim 1 in which X is amino.
Claim 8
Dependent Claim 11 words
A compound according to claim 4, said compound being 7-mandelamido-3-(4-carboxy-1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid.
Claim 9
Dependent Claim 11 words
A compound according to claim 4, said compound being 7-(α-aminophenylacetamido)-3-(4-carboxy-1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid.
Claim 10
Dependent Claim 11 words
A compound according to claim 4, said compound being 7-(α-aminophenylacetamido)-3-(4-carbethoxy-1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid.
Claim 11
Dependent Claim 11 words
A compound according to claim 4, said compound being 7-(α-amino-4-hydroxyphenylacetamido)-3-(4-carbethoxy-1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid.
Claim 12
Dependent Claim 11 words
A compound according to claim 4, said compound being 7-mandelamido-3-(5-carboxymethyl-1,2,4-triazol-3-ylthiomethyl)-3-cephem-4-carboxylic acid.
Claim 13
Dependent Claim 11 words
A compound according to claim 4, said compound being 7-(α-aminophenylacetamido)-3-(5-carboxymethyl-1,2,4-triazol-3-ylthiomethyl)-3-cephem-4-carboxylic acid.
Claim 14
Dependent Claim 11 words
A compound according to claim 4, said compound being 7-(α-amino-4-hydroxyphenylacetamido)-3-(5-carboxymethyl-1,2,4-triazol-3-ylthiomethyl)-3-cephem-4-carboxylic acid.
Claim 15
Dependent Claim 11 words
A compound according to claim 4, said compound being 7-(α-aminophenylacetamido)-3-(5-carbethoxymethyl-1,2,4-triazol-3ylthiomethyl)-3-cephem-4-carboxylic acid.
Claim 16
Dependent Claim 11 words
A compound according to claim 4, said compound being 7-(α-amino-4-hydroxyphenylacetamido)-3-(4-carbamoyl-1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid.

References Cited (Backward Citations)

NL6916151A Cited
US3759904A Cited
US3796801A Cited
US3813388A Cited
BE814546A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-11-02 1980-05-03 1980-11-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-11-02 1984-05-03 1984-11-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-11-02 1988-05-03 1988-11-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag